289 related articles for article (PubMed ID: 31641818)
21. Opioid selective antinociception following microinjection into the periaqueductal gray of the rat.
Morgan MM; Reid RA; Stormann TM; Lautermilch NJ
J Pain; 2014 Nov; 15(11):1102-1109. PubMed ID: 25106089
[TBL] [Abstract][Full Text] [Related]
22. Copaifera langsdorffii Desf. tree oleoresin-induced antinociception recruits µ
Santana VC; Marmentini BM; Cruz GG; de Jesus LC; Walicheski L; Beffa FH; Maffei THP; Streg RV; Veiga-Junior VF; Andrighetti CR; Freitas de Lima MC; de Sousa Valladão DM; de Oliveira RC; Neyra MOC; de Araújo Berber RC; Falconi-Sobrinho LL; Coimbra NC; de Oliveira R
Behav Brain Res; 2024 Mar; 461():114832. PubMed ID: 38142860
[TBL] [Abstract][Full Text] [Related]
23. Non-opioid antinociception produced by brain stem injections of improgan: significance of local, but not cross-regional, cannabinoid mechanisms.
Hough LB; Svokos K; Nalwalk JW
Brain Res; 2009 Jan; 1247():62-70. PubMed ID: 18983834
[TBL] [Abstract][Full Text] [Related]
24. PAG mu opioid receptor activation underlies sex differences in morphine antinociception.
Bernal SA; Morgan MM; Craft RM
Behav Brain Res; 2007 Feb; 177(1):126-33. PubMed ID: 17118467
[TBL] [Abstract][Full Text] [Related]
25. Metamizol, a non-opioid analgesic, acts via endocannabinoids in the PAG-RVM axis during inflammation in rats.
Escobar W; Ramirez K; Avila C; Limongi R; Vanegas H; Vazquez E
Eur J Pain; 2012 May; 16(5):676-89. PubMed ID: 22337336
[TBL] [Abstract][Full Text] [Related]
26. The involvement of orexin 1 and cannabinoid 1 receptors within the ventrolateral periaqueductal gray matter in the modulation of migraine-induced anxiety and social behavior deficits of rats.
Pourrahimi AM; Abbasnejad M; Raoof M; Esmaeili-Mahani S; Kooshki R
Peptides; 2021 Dec; 146():170651. PubMed ID: 34560171
[TBL] [Abstract][Full Text] [Related]
27. Contribution of G Protein-Coupled Receptor 55 to Periaqueductal Gray-Mediated Antinociception in the Inflammatory Pain.
Blanton H; Armin S; Muenster S; Abood M; Benamar K
Cannabis Cannabinoid Res; 2022 Jun; 7(3):274-278. PubMed ID: 35612493
[TBL] [Abstract][Full Text] [Related]
28. Distribution of CB1 cannabinoid receptors and their relationship with mu-opioid receptors in the rat periaqueductal gray.
Wilson-Poe AR; Morgan MM; Aicher SA; Hegarty DM
Neuroscience; 2012 Jun; 213():191-200. PubMed ID: 22521830
[TBL] [Abstract][Full Text] [Related]
29. Intra-periaqueductal grey microinjections of an imidazo[1,2-b]pyridazine derivative, DM2, affects rostral ventromedial medulla cell activity and shows antinociceptive effect.
Palazzo E; Rimoli MG; De Chiaro M; Guida F; Melisi D; Curcio A; de Novellis V; Marabese I; Rossi F; Abignente E; Maione S
Neuropharmacology; 2010 Mar; 58(3):660-7. PubMed ID: 19944111
[TBL] [Abstract][Full Text] [Related]
30. Change in functional selectivity of morphine with the development of antinociceptive tolerance.
Macey TA; Bobeck EN; Suchland KL; Morgan MM; Ingram SL
Br J Pharmacol; 2015 Jan; 172(2):549-61. PubMed ID: 24666417
[TBL] [Abstract][Full Text] [Related]
31. Activation of mu opioid receptors in the ventrolateral periaqueductal gray inhibits reflex micturition in anesthetized rats.
Matsumoto S; Levendusky MC; Longhurst PA; Levin RM; Millington WR
Neurosci Lett; 2004 Jun; 363(2):116-9. PubMed ID: 15172097
[TBL] [Abstract][Full Text] [Related]
32. Cannabinoid transmission in the prelimbic cortex bidirectionally controls opiate reward and aversion signaling through dissociable kappa versus μ-opiate receptor dependent mechanisms.
Ahmad T; Lauzon NM; de Jaeger X; Laviolette SR
J Neurosci; 2013 Sep; 33(39):15642-51. PubMed ID: 24068830
[TBL] [Abstract][Full Text] [Related]
33. Antinociception produced by mu opioid receptor activation in the amygdala is partly dependent on activation of mu opioid and neurotensin receptors in the ventral periaqueductal gray.
Tershner SA; Helmstetter FJ
Brain Res; 2000 May; 865(1):17-26. PubMed ID: 10814729
[TBL] [Abstract][Full Text] [Related]
34. Differential development of antinociceptive tolerance to morphine and fentanyl is not linked to efficacy in the ventrolateral periaqueductal gray of the rat.
Bobeck EN; Haseman RA; Hong D; Ingram SL; Morgan MM
J Pain; 2012 Aug; 13(8):799-807. PubMed ID: 22766006
[TBL] [Abstract][Full Text] [Related]
35. Dopaminergic mechanisms in periaqueductal gray-mediated antinociception.
Tobaldini G; Reis RA; Sardi NF; Lazzarim MK; Tomim DH; Lima MMS; Fischer L
Behav Pharmacol; 2018 Apr; 29(2 and 3-Spec Issue):225-233. PubMed ID: 29035918
[TBL] [Abstract][Full Text] [Related]
36. Intra-periaqueductal gray matter microinjection of orexin-A decreases formalin-induced nociceptive behaviors in adult male rats.
Azhdari Zarmehri H; Semnanian S; Fathollahi Y; Erami E; Khakpay R; Azizi H; Rohampour K
J Pain; 2011 Feb; 12(2):280-7. PubMed ID: 21145791
[TBL] [Abstract][Full Text] [Related]
37. Medial Prefrontal Cortical Cannabinoid CB1 Receptors Mediate Morphine-Dextromethorphan Cross State-Dependent Memory: The Involvement of BDNF/cFOS Signaling Pathways.
Ghasemzadeh Z; Rezayof A
Neuroscience; 2018 Nov; 393():295-304. PubMed ID: 30326290
[TBL] [Abstract][Full Text] [Related]
38. Activation of the P2X
Li P; Zhang Q; Xiao Z; Yu S; Yan Y; Qin Y
Mol Pain; 2018; 14():1744806918803039. PubMed ID: 30198382
[TBL] [Abstract][Full Text] [Related]
39. Electroacupuncture modulates vlPAG release of GABA through presynaptic cannabinoid CB1 receptors.
Fu LW; Longhurst JC
J Appl Physiol (1985); 2009 Jun; 106(6):1800-9. PubMed ID: 19359606
[TBL] [Abstract][Full Text] [Related]
40. Antinociception induced by stimulation of ventrolateral periaqueductal gray at the freezing threshold is regulated by opioid and 5-HT2A receptors as assessed by the tail-flick and formalin tests.
de Luca MC; Brandão ML; Motta VA; Landeira-Fernandez J
Pharmacol Biochem Behav; 2003 May; 75(2):459-66. PubMed ID: 12873638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
